Biological
CL184 clinical trials
Also written CL184.
- studies test it
- 3
- open now
- 0
- in phase 3
- 0
- first study started
- 2008
How studies write it
Studies that test it under each name
Development codes
Studies by the year they started
3 studies that test it; most in 2008 (2)
| Year | Studies |
|---|---|
| 2008 | 2 |
| 2011 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 2
- 3
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 3 · Other 0
Often tested with
Tested in the same studies.
Rabies virus strain PM-1503-3M antigen (propiolactone inactivated) (1) · Rabies Vaccines (1)
Studies
Open first, then newest update. How each study uses CL184 is read from its arms, and is right about nine times in ten.
Testing it · 3
- Rabies Virus Neutralizing Activity and Safety of CL184, a Monoclonal Antibody Cocktail, in Simulated Rabies Post-Exposure Prophylaxis in Healthy AdultsCompletedPhase 2Crucell Holland BVNCT01228383Written as Rabies virus-specific monoclonal antibodies
- Randomized Phase II Trial on Safety and Neutralizing Activity of CL184 and Rabies Vaccine Versus Human Rabies Immune Globulin (HRIG) and Rabies Vaccine in Children and AdolescentsCompletedPhase 2Crucell Holland BVNCT00708084Written as CL184
- A Randomized Phase II Trial to Compare the Safety and Neutralizing Activity of CL184 in Combination With Rabies Vaccine vs. HRIG or Placebo in Combination With Rabies Vaccine in Healthy Adult SubjectsCompletedPhase 2Crucell Holland BVNCT00656097Written as CL184